3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
6
Uterine Cervical Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Clear-cell metastatic renal cell carcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Advanced Renal Cell Carcinoma (RCC)
1
Advanced Non-small Cell Lung Cancer
1
Adenocarcinoma, Mucinous
1
Interventions
fludarabine
11
Cyclophosphamide
10
fludarabine phosphate
8
Whole-Body Irradiation
7
Specimen Handling
7
Cytarabine
7
Biopsy
7
venetoclax
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Injections
5
CPX-351
5
decitabine and cedazuridine drug combination
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Cyclosporine
4
ivosidenib
3
X-Rays
3
Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
treosulfan
2
ruxolitinib
2
luspatercept
2
gilteritinib
2
Sirolimus
2
Photons
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Axitinib
×
30 days
×
Clear all
No trials found.